Skip to main content
Fig. 5 | Journal of Translational Medicine

Fig. 5

From: Expression and clinical significance of LAG-3, FGL1, PD-L1 and CD8+T cells in hepatocellular carcinoma using multiplex quantitative analysis

Fig. 5

HCC-specific OS and DFS of LAG-3+cells levels or plus FGL1 status on TC in relation to CD8+T cells densities in the combined cohorts. Kaplan–Meier analysis of OS (a) and DFS (b) based on the combination of the levels of LAG-3+cells and CD8+T cells. HCC-specific OS (c) and DFS (d) of LAG-3+cells levels plus FGL1 status on TC in relation to CD8+T cells densities in the combined cohorts using Kaplan–Meier analysis. Others: the patients who are either high levels of LAG-3+cells or positive FGL1 status on TC or both low densities of LAG-3+cells and negative FGL1 status on TC. Differences in survival were analyzed by log-rank test. The number of patients at risk was reported. TC tumor cells, IC immune cells, OS Overall survival, DFS Disease-free survival

Back to article page